Navellier & Associates Inc Abbott Laboratories Transaction History
Navellier & Associates Inc
- $792 Million
- Q4 2024
A detailed history of Navellier & Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Navellier & Associates Inc holds 5,587 shares of ABT stock, worth $729,718. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,587
Previous 6,860
18.56%
Holding current value
$729,718
Previous $782,000
19.31%
% of portfolio
0.08%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,336Shares Held
1.36BCall Options Held
10MPut Options Held
9.48M-
Vanguard Group Inc Valley Forge, PA169MShares$22 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.88 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.07 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...